- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17:36 | As buzz on Califf FDA nom heats up, industry and agency insiders offer a strong nod for the 'perfect' choice | ||
| 17:36 | Covid-19 roundup: Moderna says vaccine produces 'strong' response in 5- to 11-year-olds; Aspen Pharmacare plans to up vaccine production in South Africa - report | ||
| 17:36 | Avenue Therapeutics lands an FDA adcomm for troubled flagship drug; FDA approves eye injection treatment for fluid buildup | ||
| 16:36 | Feud between bluebird and a rival continues with a lawsuit and allegations of patent fraud | ||
| 16:36 | A combo of AstraZeneca's Imfinzi and chemo wins where others have failed in pivotal biliary tract test | ||
| 16:36 | Recent court decision pushes FDA to reject and reclassify drug-device combo, crushing shares | ||
| 16:36 | Endo taps bent veggie in first Xiaflex brand campaign for Peyronie's disease curved erection condition | ||
| 15:36 | Merck's experimental HIV drug islatravir hits with a PhIII combo win and FDA filing plans | ||
| 15:36 | A transatlantic biotech flags a painful PhIII cancer flop, waving a white flag | ||
| 14:36 | Another NASH player retreats from battered field after toxicology study flags potential delay | ||
| 14:36 | Just as first Lucentis biosimilar wins approval, Roche snags an OK for an easier route of administration | ||
| 13:36 | Sanofi, Regeneron gear up for new Dupixent filing after clearing second PhIII for eosinophilic esophagitis | ||
| 13:36 | After passing on Acceleron, Bristol Myers Squibb eyes bolt-on acquisition of autoimmune specialist - report | ||
| 12:36 | Novartis' second attempt to replicate a stunning cancer result falls flat | ||
| Sa | So - that pig-to-human transplant; Potential diabetes cure reaches patient; Accused MIT scientist lashes back; and more | ||
| Fr | Xilio Therapeutics goes public as biopharma IPOs rumble forward in Q4 | ||
| Fr | A new Treg player emerges with $46M and backing from Takeda | ||
| Fr | Oncopeptides stock craters as it pulls cancer drug Pepaxto from the market | ||
| Fr | Ocular Therapeutix hammered by a PhII failure in dry eye disease - shares tank | ||
| Fr | No, scientists are not any closer to pig-to-human transplants than they were last week | ||
| Fr | Agenus calls out FDA for playing favorites with Merck, pulls cervical cancer BLA at agency's request | ||
| Fr | Former MIT scientist David Sabatini fires back at accuser, Whitehead Institute for 'false' harassment allegations | ||
| Fr | Following August meltdown, Zymergen hints at salvage plans - cutting jobs and renegotiating loans | ||
| Fr | Covid-19 roundup: White House pushes for IP waiver support to WTO; Rare nerve disorder listed as AstraZeneca side effect in UK | ||
| Fr | Sanofi, Regeneron etch out another PhIII victory for Dupixent, easing severe itch and clearing lesions |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
